Health alliance for prudent prescribing and yield of antibiotics in a patient-centred perspective (HAPPY PATIENT): a before-and-after intervention and implementation study protocol.
After-hours care
Anti-bacterial agents
Antimicrobial stewardship
Medical audit
Nursing homes
Pharmacies
Primary health care
Journal
BMC primary care
ISSN: 2731-4553
Titre abrégé: BMC Prim Care
Pays: England
ID NLM: 9918300889006676
Informations de publication
Date de publication:
02 05 2022
02 05 2022
Historique:
received:
26
01
2022
accepted:
18
04
2022
entrez:
3
5
2022
pubmed:
4
5
2022
medline:
6
5
2022
Statut:
epublish
Résumé
Excessive and inappropriate use of antibiotics is the most important driver of antimicrobial resistance. The aim of the HAPPY PATIENT project is to evaluate the adaptation of European Union (EU) recommendations on the prudent use of antimicrobials in human health by evaluating the impact of a multifaceted intervention targeting different categories of healthcare professionals (HCPs) on common community-acquired infectious diseases, especially respiratory and urinary tract infections. HAPPY PATIENT was initiated in January 2021 and is planned to end in December 2023. The partners of this project include 15 organizations from 9 countries. Diverse HCPs (doctors, nurses, pharmacists, and pharmacy technicians) will be audited by the Audit Project Odense (APO) method before and after an intervention in four different settings: general practice, out of hours services, nursing homes and community pharmacies in four high antibiotic prescribing countries (France, Poland, Greece, and Spain) and one low prescribing country (Lithuania). About 25 individuals from each professional group will be recruited in each country, who will register at least 25 patients with community-acquired infections during each audit period. Shortly before the second registration participants will undertake a multifaceted intervention and will receive the results from the first registration to allow the identification of possible quality problems. At these meetings participants will receive training courses on enhancement of communication skills, dissemination of clinical guidelines with recommendations for diagnosis and treatment, posters for the waiting rooms, and leaflets for patients. The results of the second registration will be compared with those obtained in the first audit. HAPPY PATIENT is an EU-funded project aimed at contributing to the battle against antibiotic resistance through improvement of the quality of management of common community-acquired infections based on interventions by different types of HCPs. It is hypothesized that the use of multifaceted strategies combining active intervention will be effective in reducing inappropriate prescribing and dispensing of antibiotics. EU Health programmes project database https://webgate.ec.europa.eu/chafea_pdb/health/projects/900024/summary ; date of registration: 1 January 2021.
Sections du résumé
BACKGROUND
Excessive and inappropriate use of antibiotics is the most important driver of antimicrobial resistance. The aim of the HAPPY PATIENT project is to evaluate the adaptation of European Union (EU) recommendations on the prudent use of antimicrobials in human health by evaluating the impact of a multifaceted intervention targeting different categories of healthcare professionals (HCPs) on common community-acquired infectious diseases, especially respiratory and urinary tract infections.
METHODS/DESIGN
HAPPY PATIENT was initiated in January 2021 and is planned to end in December 2023. The partners of this project include 15 organizations from 9 countries. Diverse HCPs (doctors, nurses, pharmacists, and pharmacy technicians) will be audited by the Audit Project Odense (APO) method before and after an intervention in four different settings: general practice, out of hours services, nursing homes and community pharmacies in four high antibiotic prescribing countries (France, Poland, Greece, and Spain) and one low prescribing country (Lithuania). About 25 individuals from each professional group will be recruited in each country, who will register at least 25 patients with community-acquired infections during each audit period. Shortly before the second registration participants will undertake a multifaceted intervention and will receive the results from the first registration to allow the identification of possible quality problems. At these meetings participants will receive training courses on enhancement of communication skills, dissemination of clinical guidelines with recommendations for diagnosis and treatment, posters for the waiting rooms, and leaflets for patients. The results of the second registration will be compared with those obtained in the first audit.
DISCUSSION
HAPPY PATIENT is an EU-funded project aimed at contributing to the battle against antibiotic resistance through improvement of the quality of management of common community-acquired infections based on interventions by different types of HCPs. It is hypothesized that the use of multifaceted strategies combining active intervention will be effective in reducing inappropriate prescribing and dispensing of antibiotics.
STUDY REGISTRATION
EU Health programmes project database https://webgate.ec.europa.eu/chafea_pdb/health/projects/900024/summary ; date of registration: 1 January 2021.
Identifiants
pubmed: 35501712
doi: 10.1186/s12875-022-01710-1
pii: 10.1186/s12875-022-01710-1
pmc: PMC9063370
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
102Informations de copyright
© 2022. The Author(s).
Références
Fam Pract. 2021 Jun 17;38(3):259-264
pubmed: 33215207
J R Coll Gen Pract. 1972 May;22(118):310-5
pubmed: 5073372
Scand J Prim Health Care. 2005 Mar;23(1):42-6
pubmed: 16025873
Elife. 2018 Dec 18;7:
pubmed: 30560781
BMC Med. 2010 Oct 20;8:63
pubmed: 20961442
BMC Fam Pract. 2011 Jun 20;12:52
pubmed: 21689406
Curr Opin Infect Dis. 2021 Oct 1;34(5):423-431
pubmed: 34267046
Fam Pract. 2006 Apr;23(2):198-202
pubmed: 16243954
Br J Gen Pract. 2022 Apr 28;72(718):235-236
pubmed: 35483949
Antibiotics (Basel). 2017 Dec 14;6(4):
pubmed: 29240687
PLoS One. 2013 Oct 23;8(10):e76691
pubmed: 24194845
Antibiotics (Basel). 2013 Sep 16;2(3):439-49
pubmed: 27029312
Mayo Clin Proc. 2011 Feb;86(2):156-67
pubmed: 21282489
J Antimicrob Chemother. 2021 Jul 26;76(12 Suppl 2):ii68-ii78
pubmed: 34312659
BMJ Open. 2015 Sep 30;5(9):e008592
pubmed: 26423853
J Clin Pharm Ther. 2018 Feb;43(1):59-64
pubmed: 28833324
Infect Drug Resist. 2019 Dec 20;12:3903-3910
pubmed: 31908502